Fluocinolone acetonide 0.01% in peanut oil: Safety and efficacy data in the treatment of childhood atopic dermatitis in infants as young as 3 months of age

Pediatric Dermatology

Volumn 26, Issue 3, 2009, Pages 262-268

  Dohil, Magdalene A ^a   Alvarez Connelly, Elizabeth ^b   Eichenfield, Lawrence F ^a  

^a RADY CHILDREN'S HOSPITAL   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIS OIL; FLUOCINOLONE ACETONIDE; FS BODY OIL; HYDROCORTISONE; UNCLASSIFIED DRUG;

ADRENAL SUPPRESSION; ARTICLE; ATOPIC DERMATITIS; BODY SURFACE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; ECZEMA; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INFANT; LICHENOID ERUPTION; MALE; MULTICENTER STUDY; OPEN STUDY; PARENT; PATIENT MONITORING; PRESCHOOL CHILD; PRIORITY JOURNAL; PRURIGO; PRURITUS; RATING SCALE; SIDE EFFECT; SKIN ATROPHY; TELANGIECTASIA; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS; ARACHIS HYPOGAEA; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; FEMALE; FLUOCINOLONE ACETONIDE; HUMANS; HYDROCORTISONE; INFANT; MALE; PLANT OILS; VEHICLES;

EID: 67650470366     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2008.00856.x     Document Type: Article

References (21)

1. Larsen FS, Hanifin JM. Epidemiology of atopic dermatitis. Immunol Allergy Clin North Am 2002 22 : 1.
2. Rajka G. Clinical aspects. In : Rajka G, ed. Essential aspects of atopic dermatitis. Berlin : Spring-Verlag, 1989 : 4.
3. Kiebert G, Sorensen SV, Revicki D et al. Atopic dermatitis is associated with a decrement in health-related quality of life. Int J Dermatol 2002 41 : 151.
4. Paller AS, McAlister RO, Doyle JJ et al. Perceptions of physicians and pediatric patients about atopic dermatitis, its impact, and its treatment. Clin Pediatr 2002 41 : 323.
5. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998 351 : 1225.
6. Eichenfield LF, Hanifin JM, Luger TA et al. Consensus conference on pediatric atopic dermatitis. J Am Acad Dermatol 2003 49 : 1088.
7. Dohil MA, Eichenfield LF. A treatment approach for atopic dermatitis. Pediatr Ann 2005 34 : 201.
8. Cookson W. The immunogenetics of asthma and eczema: a new focus on the epithelium. Nat Rev Immunol 2004 4 : 978.
9. Callen J, Chamlin S, Eichenfield LF et al. A systematic review of the safety of topical therapies for atopic dermatitis. Br J Dermatol 2007 156 : 203 221. (Pubitemid 46095948)
10. Sidbury R, Poorsattar S. Pediatric atopic dermatitis: should we treat it differently? Dermatol Ther 2006 19 : 83.
11. Boguniewcz M. Topical treatment of atopic dermatitis. Immunol Allergy Clin North Am 2004 24 : 631 644, vi-vii.
12. Buys LM. Treatment options for atopic dermatitis. Am Fam Physician 2007 75 : 523 528.
13. Beattie PE, Lewis-Jones MS. Parental knowledge of topical therapies in the treatment of childhood atopic dermatitis. Clin Exp Dermatol 2003 28 : 549 553. (Pubitemid 37100564)
14. Fluhr JW, Junger M. The price for treatment of chronic skin diseases: different approaches. Dermatology 2007 214 : 6 7. (Pubitemid 46032993)
15. Charman CR, Morris AD, Williams HC. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol 2000 142 : 931 936. (Pubitemid 30304603)
16. Zuberbier T, Orlow SJ, Paller AS et al. Patient perspectives on the management of atopic dermatitis. J Allergy Clin Immunol 2006 118 : 226 232. (Pubitemid 43946465)
17. Hultsch T, Kapp A, Spergel J. Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis. Dermatology 2005 211 : 174.
18. Breuer K, Werfel T, Kapp A. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis. Am J Clin Dermatol 2005 6 : 65.
19. Zhai H, Ramirez RG, Maibach HI. Hydrating effects of a corticoid oil formulation and its vehicle on human skin. Skin Pharmacol Appl Skin Physiol 2003 16 : 367 371. (Pubitemid 37256071)
20. Paller AS, Nimmagadda S, Schachner L et al. Fluocinolone acetonide 0.01% in peanut oil: therapy for childhood atopic dermatitis, even in patients who are peanut sensitive. J Am Acad Dermatol 2003 48 : 569 577. (Pubitemid 36397021)
21. Teuber SS, Brown RL, Haapanen LAD. Allergenicity of gourmet nut oils processed by different methods. J Allergy Clin Immunol 1997 99 : 502 507. (Pubitemid 27173088)